Discover the potential of 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3- methyl-1-[(4-methyl-2 quinazolinyl)methyl]-1H-purine-2,6-dione (CAS: 853029-57-9 with Zero C Materials. This compound is essential as an intermediate for linagliptin, a vital pharmaceutical used in diabetes treatment.